Using the shot

Zealthy vs Remedy Meds

$216/mo against $399/mo for tirzepatide. Which is worth it, and for whom.

Illustration of two objects on a balance scale

Updated 2026-09-18

How we are paid: one company on this page — Coreage Rx — pays us a commission if you sign up through our link. It does not buy a better score, a higher position, or the removal of a single criticism. Our rating method and full disclosure are both public.


Both sell tirzepatide. Zealthy costs $216 a month and Remedy Meds costs $399, a difference of $183 a month or about $2,196 a year. The other differences matter more than the money if this is your first course.

Zealthy is low-cost entry with insurance routing. Remedy Meds is flat pricing with unlimited clinician access. They are not aimed at the same person, and the cheaper one is not automatically the right answer — particularly if this is your first course and you expect a slow titration.

What this means for your titration. Remedy Meds holds one price at every dose and Zealthy does not — so this gap widens as you titrate toward a therapeutic dose, exactly when you can least afford a surprise.

Side by side

ZealthyRemedy Meds
Advertised from$216$279
Membership on topNoneNone
True monthly cost$216$399
Roughly, per year$2,592$4,788
Price includes medicationYesYes
Names its pharmacyNot publishedNot published
Our score3.5 / 53.5 / 5

Prices verified 2026-09-18. "True monthly cost" is what you are billed in month two, once any introductory rate has lapsed and any membership has renewed.

The differences that affect treatment

They differ on 2 of the 7 things we track, and behave the same on the other 5. The differences are what the price gap is actually buying.

ZealthyRemedy Meds
Price is the same at every doseNoYes
Will pursue insurance coverageYesNo

What each programme publishes: Zealthy

  • First month advertised at $39.
  • Compounded semaglutide priced from about $151/month.
  • Compounded tirzepatide priced from about $216/month.
  • Where insurance covers branded semaglutide, patient cost can fall to roughly $25/month.

Where it wins: Compounded pricing is competitive without a separate membership charge. Watch for: The widely quoted $25/month is an insured price. Cash payers should plan on $151+ for semaglutide.

What each programme publishes: Remedy Meds

  • Compounded semaglutide priced at $299/month flat, regardless of dose.
  • Compounded tirzepatide priced at $399/month flat, regardless of dose.
  • First month of tirzepatide discounted to $279, then $399/month.
  • Medication is included in the monthly fee rather than billed separately.
  • Unlimited clinician access, check-ins and dose adjustments included.
  • Branded Zepbound offered at around $1,399/month.

Where it wins: Genuinely flat pricing — the dose can go to the top of the ladder without the bill moving. Watch for: The $279 introductory tirzepatide month renews at $399. Budget from the renewal figure.

Strengths of each

Zealthy.

  • Compounded pricing is competitive without a separate membership charge.
  • Will pursue insurance coverage rather than defaulting to cash pay.
  • Low-friction $39 first month.

Remedy Meds.

  • Genuinely flat pricing — the dose can go to the top of the ladder without the bill moving.
  • Unlimited clinician access is included rather than sold as an upgrade.
  • Medication is inside the monthly fee, so there is no second bill.

How they score

What we weighWeightZealthyRemedy Meds
True monthly cost30%3.82.9
Price honesty20%3.54
Clinical support20%3.44
Pharmacy sourcing15%3.53.5
Cancelling15%3.33.4

Zealthy scores higher overall at 3.5 out of 5. The weights are published on how we rate, and so is the note about which of these is our paid featured partner.

Which suits you

  • Pick Zealthy if cost is the binding constraint. Over a year the gap is about $2,196, which is real money for the same class of medication.
  • Pick Remedy Meds if what it does better matters to you — genuinely flat pricing — the dose can go to the top of the ladder without the bill moving.
  • Ask both which pharmacy compounds the medication and whether it is a 503A or 503B facility. Neither publishes it.

The verdict

For most people starting out, Zealthy at $216 a month is the more defensible choice on arithmetic alone. Remedy Meds earns its premium only if you will actually use what it does differently. Read the full reviews before deciding: Zealthy and Remedy Meds.

How they sit against everyone else

ProgrammePer monthDose-priceOur score
Coreage Rx
Best overall on true monthly cost
$199Flat4.5
Trimi
Lowest flat price with named pharmacies
$125Varies4.6
PlexusDx
Pharmacy transparency and genetic testing
$189Varies4.4
Ozari Health
Lowest advertised semaglutide price
$125Varies4.4
Fifty 410
Prepaid blocks with no subscription
$133Varies4.2
Ivím Health
Unlimited clinician access
$199Varies4
Mochi Health
Insurance concierge support
$278
incl. $79 fee
Varies3.6
Coby Health
Multi-month value with supplies included
$239Varies3.6
Hims & Hers
Widest range of formats
$238
incl. $39 fee
Varies3.5
Ro
Branded medication with insurance help
$448
incl. $149 fee
Varies3.5
Zealthy
Low-cost entry with insurance routing
$216Varies3.5
LifeMD
Insurance coordination
$149Varies3.5

Read next

  • Zealthy tirzepatide review

    Low-cost entry with insurance routing. How they handle your dose ladder, what support looks like when side effects hit, and what you actually pay — $216 a month.

  • Remedy Meds tirzepatide review

    Flat pricing with unlimited clinician access. How they handle your dose ladder, what support looks like when side effects hit, and what you actually pay — $399 a month.

  • How to spot a bad seller

    The FDA sent more than 55 warning letters to online GLP-1 sellers in one day. Here is how to tell a licensed programme from the rest.

  • The twelve-month cost

    Month one is the cheapest month you will have. Here is the full-year arithmetic, including the costs nobody puts in the advert.

  • Best programmes if this is your first time

    Ranked on how they price the dose ladder and how reachable support is — the two things that decide whether a beginner stays on treatment.